DOCSLIB.ORG

Automated DNA Sequencing

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Automated DNA Sequencing Automated DNA Sequencing Chemistry Guide ©Copyright 1998, The Perkin-Elmer Corporation This product is for research purposes only. ABI PRISM, MicroAmp, and Perkin-Elmer are registered trademarks of The Perkin-Elmer Corporation. ABI, ABI PRISM, Applied Biosystems, BigDye, CATALYST, PE, PE Applied Biosystems, POP, POP-4, POP-6, and Primer Express are trademarks of The Perkin-Elmer Corporation. AmpliTaq, AmpliTaq Gold, and GeneAmp are registered trademarks of Roche Molecular Systems, Inc. Centricon is a registered trademark of W. R. Grace and Co. Centri-Sep is a trademark of Princeton Separations, Inc. Long Ranger is a trademark of The FMC Corporation. Macintosh and Power Macintosh are registered trademarks of Apple Computer, Inc. pGEM is a registered trademark of Promega Corporation. Contents 1 Introduction. 1-1 New DNA Sequencing Chemistry Guide . 1-1 Introduction to Automated DNA Sequencing . 1-2 ABI PRISM Sequencing Chemistries . 1-5 PE Applied Biosystems DNA Sequencing Instruments . 1-7 Data Collection and Analysis Settings . 1-12 2 ABI PRISM DNA Sequencing Chemistries . 2-1 Overview . 2-1 Dye Terminator Cycle Sequencing Kits . 2-2 Dye Primer Cycle Sequencing Kits . 2-8 Dye Spectra . 2-12 Chemistry/Instrument/Filter Set Compatibilities . 2-13 Dye/Base Relationships for Sequencing Chemistries . 2-14 Choosing a Sequencing Chemistry. 2-15 3 Performing DNA Sequencing Reactions . 3-1 Overview . 3-1 DNA Template Preparation . 3-2 Sequencing PCR Templates . 3-10 DNA Template Quality. 3-15 DNA Template Quantity. 3-17 Primer Design and Quantitation . 3-18 Reagent and Equipment Considerations. 3-20 Preparing Cycle Sequencing Reactions . 3-21 Cycle Sequencing . 3-27 Preparing Extension Products for Electrophoresis . 3-33 Removing Unincorporated Dye Terminators . 3-34 Preparing Dye Primer Reaction Products for Electrophoresis . 3-46 Preparing and Loading Samples for Gel Electrophoresis. 3-50 Preparing and Loading Samples for Capillary Electrophoresis . 3-53 4 Optimizing Gel Electrophoresis . 4-1 Introduction . 4-1 Reagents . 4-2 i Avoiding Problems with Sequencing Gels . 4-4 5 Optimizing Capillary Electrophoresis . 5-1 Introduction . 5-1 Capillary Electrophoresis Consumables . 5-2 Optimizing Electrokinetic Injection . 5-4 Optimizing Electrophoresis Conditions. 5-7 Run Parameters for Specific Sequencing Chemistries. 5-8 6 Optimizing Software Settings. 6-1 Introduction . 6-1 Choosing a Run Module . 6-2 Choosing a Dye Set/Primer (Mobility) File. 6-3 Choosing the Correct Basecaller . 6-6 Creating an Instrument (Matrix) File. 6-7 Setting the Data Analysis Range . 6-15 7 Data Evaluation and Troubleshooting . 7-1 Overview . 7-1 Data Evaluation . 7-2 Practical Examples of Data Evaluation . 7-10 Troubleshooting Sequencing Reactions. 7-16 Troubleshooting DNA Sequence Composition Problems . 7-30 Troubleshooting Sequencing Data. 7-39 Troubleshooting Gel Electrophoresis on the ABI 373 and ABI PRISM 377 . 7-44 Troubleshooting Capillary Electrophoresis on the ABI PRISM 310. 7-55 Troubleshooting Software Settings . 7-62 A Gel Preparation . A-1 Introduction . A-1 Protocol and Run Conditions for 19:1 Polyacrylamide Gels . A-2 Protocol and Run Conditions for 29:1 Polyacrylamide Gels. A-6 Protocol and Run Conditions for Long Ranger and PAGE-PLUS Gels . A-10 Preparing APS, TBE Buffer, and Deionized Formamide . A-15 ii B IUB Codes . .B-1 C References . .C-1 D Technical Support . .D-1 How to Get Help. D-1 E Part Numbers. .E-1 ABI PRISM DNA Sequencing Kits and Reagents. .E-1 ABI PRISM 310 Genetic Analyzer . .E-5 ABI PRISM 377 DNA Sequencer . .E-8 ABI 373 DNA Sequencer . .E-9 Documentation and Software . .E-10 Index iii Introduction 1 1 New DNA Sequencing Chemistry Guide Purpose Since the original DNA Sequencing Chemistry Guide was published in early 1995, PE Applied Biosystems has released two new instrument platforms, five new sequencing chemistries, and a new sequencing enzyme. To accommodate this new information, we have written the Automated DNA Sequencing Chemistry Guide. This updated guide provides the following: ♦ An introduction to automated DNA sequencing ♦ Descriptions of PE Applied Biosystems sequencing instruments, chemistries, and software ♦ Detailed protocols for preparing DNA templates, performing cycle sequencing, and preparing the extension products for electrophoresis.
Load more

Recommended publications
  • Applied Biosystems 3730 and 3730Xl DNA Analyzers
    SPECIFICATION SHEET 3730 and 3730xl DNA Analyzers Applied Biosystems 3730 and 3730xl DNA Analyzers Introduction Applied Biosystems 3730 & 3730xl DNA Analyzers were developed to meet the growing needs of institutions ranging from core and research labs in academia, government, and medicine to biotechnology, pharmaceuticals, and genome centers. These high-throughput instruments couple advances in automation and optics with proprietary Applied Biosystems reagents and software to support a diverse range Key Features Key Benefits of genetic analysis projects. By • Dual-side capillary illumination • Highest-quality DNA sequencing data dramatically improving data quality, at lowest cost • Backside-thinned CCD significantly reducing total cost per – POP-7™ Polymer separation matrix sample, and enabling more runs per • Integrated auto-sampler and sample increases read length and reduces day, 3730/3730xl DNA Analyzers make plate stacker run time it quicker and easier for investigators • Onboard piercing station to get meaningful results in evolving – Multiple run modules provide options genomic applications. Whether your • Internal barcode reader for targeted length of read lab is involved in de novo sequencing, • Onboard polymer for up to 100 runs – High optical sensitivity reduces DNA resequencing, microsatellite-based and reagent consumption fragment analysis, or SNP genotyping, • Automated basecalling and quality 3730/3730xl DNA Analyzers are the value assignment – In-capillary detection consumes ideal platform for better, faster, cheaper •
    [Show full text]
  • Comparison of ABI 3730XL Capillary Sequencer And
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Lehigh University: Lehigh Preserve Lehigh University Lehigh Preserve Theses and Dissertations 2008 Comparison of ABI 3730XL capillary sequencer and Megabace4500 capillary sequencer : the two machines are evaluated for their complexity, accuracy, reproducibility, productivity and cost effectiveness Jacques P. Thimote Lehigh University Follow this and additional works at: http://preserve.lehigh.edu/etd Recommended Citation Thimote, Jacques P., "Comparison of ABI 3730XL capillary sequencer and Megabace4500 capillary sequencer : the two machines are evaluated for their complexity, accuracy, reproducibility, productivity and cost effectiveness" (2008). Theses and Dissertations. Paper 1021. This Thesis is brought to you for free and open access by Lehigh Preserve. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of Lehigh Preserve. For more information, please contact [email protected]. Thimote, Jacques P. t Comparison of ABI 3730XL Capillary Sequencer and Megabace 4500 .. Capillary Sequencer... September 2008 . COMPARISON OF ABI 3730XL CAPILLARY SEQUENCER AND MEGABACE4500 CAPILLARY SEQUENCER: THE TWO MACHINES ARE EVALUATED FOR THEIR COMPLEXITY, ACCURACY, REPRODUCIBILITY, PRODUCTIVITY AND COST EFFECTIVENESS. by Jacques P. Thimote A Thesis Pres:ented to the Graduate--and Research Committee ofLehigh University in Candidacy for the Degree of Master ofScience III Chemistry Lehigh University September, 2008 Table of Contents Certificate ofapproval .ii Abstract. .1 Introduction '" 2 Materials Section 5 Experimental Section " " , 6 Discussion Section .Complexity 9 Accuracy 11 Productivity "" '" 13 Reproducibility : 13 Cost effectiveness 14 Conclusion 16 References , 17 Biography , '" , .1·8 iii Abstract The purpose of this research is to compare the ABI 3730xl sequencer to the Megabace 4500 sequencer by evaluating the sequence data obtained from both machines with DNA sample that were cloned into plasmid or M13 phase.
    [Show full text]
  • Download This Article As A
    UNDERSTAND | Biology, Health A new method of genetic sequencing is making it easier than ever to decode DNA. Iaroslav Neliubov/Shutterstock.com Neliubov/Shutterstock.com Iaroslav Decoding DNA with a pocket-sized sequencer USB-powered sequencers smaller than your smartphone could revolutionise the way we decode DNA – in hospitals, in remote locations and even in space. By Kerstin Göpfrich and Kim Judge What were the biggest technological developments of the Now, another technology is being revolutionised in a 20th century? Computers may be the first thing that comes similar way: the DNA sequencer. to mind: early computers for military and commercial DNA stores the genetic information that is passed down use took up a whole room before they were transformed between generations. Similar to the way computers store into smaller, affordable consumer products in the 1980s. information as a string of zeros and ones, the information Computing power has advanced at such a rate that the in DNA is stored as a code of four bases: A, T, C and G smartphones we use today can perform tasks that even the (adenine, thymine, cytosine and guanine). most powerful computers could not achieve decades ago. www.scienceinschool.org I Science in School I Issue 43 : Spring 2018 I 17 Biology, Health | UNDERSTAND In 2003, the first human genome – the How does nanopore nanopore sequencer, which is plugged complete set of genetic information – sequencing work? into a laptop via a standard USB cable was sequenced. It took seven years, 150 (figure 1). scientists and 3 billion US dollars (2.5 Portable DNA sequencers have been on Inside the nanopore sequencer, an billion euros) to complete the mammoth the market since 2015.
    [Show full text]
  • Document Title: Development and Evaluation of a Whole Genome Amplification Method for Accurate Multiplex STR Genotyping of Compromised Forensic Casework Samples
    The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: Development and Evaluation of a Whole Genome Amplification Method for Accurate Multiplex STR Genotyping of Compromised Forensic Casework Samples Author: Tracey Dawson Cruz, Ph.D. Document No.: 227501 Date Received: July 2009 Award Number: 2005-DA-BX-K002 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this Federally- funded grant final report available electronically in addition to traditional paper copies. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. FINAL TECHNICAL REPORT Development and Evaluation of a Whole Genome Amplification Method for Accurate Multiplex STR Genotyping of Compromised Forensic Casework Samples NIJ Award #: 2005-DA-BX-K002 Author: Tracey Dawson Cruz 1 This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S.
    [Show full text]
  • List of SARS-Cov-2 Diagnostic Test Kits and Equipments Eligible For
    Version 33 2021-09-24 List of SARS-CoV-2 Diagnostic test kits and equipments eligible for procurement according to Board Decision on Additional Support for Country Responses to COVID-19 (GF/B42/EDP11) The following emergency procedures established by WHO and the Regulatory Authorities of the Founding Members of the GHTF have been identified by the QA Team and will be used to determine eligibility for procurement of COVID-19 diagnostics. The product, to be considered as eligible for procurement with GF resources, shall be listed in one of the below mentioned lists: - WHO Prequalification decisions made as per the Emergency Use Listing (EUL) procedure opened to candidate in vitro diagnostics (IVDs) to detect SARS-CoV-2; - The United States Food and Drug Administration’s (USFDA) general recommendations and procedures applicable to the authorization of the emergency use of certain medical products under sections 564, 564A, and 564B of the Federal Food, Drug, and Cosmetic Act; - The decisions taken based on the Canada’s Minister of Health interim order (IO) to expedite the review of these medical devices, including test kits used to diagnose COVID-19; - The COVID-19 diagnostic tests approved by the Therapeutic Goods Administration (TGA) for inclusion on the Australian Register of Therapeutic Goods (ARTG) on the basis of the Expedited TGA assessment - The COVID-19 diagnostic tests approved by the Ministry of Health, Labour and Welfare after March 2020 with prior scientific review by the PMDA - The COVID-19 diagnostic tests listed on the French
    [Show full text]
  • A Method for DNA Sequencing Using RNA Polymerase
    Proc. Natl. Acad. Sci. USA Vol. 95, pp. 3455–3460, March 1998 Biochemistry Transcriptional sequencing: A method for DNA sequencing using RNA polymerase NOBUYA SASAKI*, MASAKI IZAWA*†,MASANORI WATAHIKI†,KAORI OZAWA‡,TAKUMI TANAKA‡,YUKO YONEDA†, SHUJI MATSUURA‡,PIERO CARNINCI*, MASAMI MURAMATSU*, YASUSHI OKAZAKI*, AND YOSHIHIDE HAYASHIZAKI*§ *Genome Science Laboratory, Tsukuba Life Science Center, The Institute of Physical and Chemical Research, 3-1-1 Koyadai, Tsukuba, Ibaraki 305, Japan; †Research and Development, Nippon Gene Co., Ltd., 1-29, Tonya-machi, Toyama, 930 Japan; and ‡Osaka Research Laboratories, Wako Pure Chemical Industries, Ltd., 6-1, Takada-cho, Amagasaki, Hyogo 661, Japan Communicated by Webster K. Cavenee, University of California, San Diego, La Jolla, CA, December 24, 1997 (received for review November 20, 1997) ABSTRACT We have developed a sequencing method direct sequencing of PCR products by using Dye-terminator based on the RNA polymerase chain termination reaction with chemistry, unreacted 29-dNTP and primers must be eliminated rhodamine dye attached to 3*-deoxynucleoside triphosphate to avoid interference with the subsequent sequencing reaction. (3*-dNTP). This method enables us to conduct a rapid iso- Although efforts have been made to quickly purify the PCR thermal sequencing reaction in <30 min, to reduce the amount product such as enzymatic degradation using exonuclease I of template required, and to do PCR direct sequencing without and shrimp alkaline phosphatase, most protocols are time- the elimination of primers and 2*-dNTP, which disturbs the consuming, laborious, and expensive (7, 8). Sanger sequencing reaction. An accurate and longer read To overcome the above problems, we pursued a completely length was made possible by newly designed four-color dye- different approach.
    [Show full text]
  • Rutgers Clinical Genomics Laboratory Taqpath SARS-Cov-2 Assay EUA Summary
    Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay EUA Summary ACCELERATED EMERGENCY USE AUTHORIZATION (EUA) SUMMARY SARS-CoV-2 ASSAY (Rutgers Clinical Genomics Laboratory) For in vitro diagnostic use Rx only For use under Emergency Use Authorization (EUA) Only (The Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay will be performed in the Rutgers Clinical Genomics Laboratory, a Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a certified high-complexity laboratory, per the Instructions for Use that were reviewed by the FDA under this EUA). INTENDED USE The Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay is a real-time reverse transcription polymerase chain reaction (rRT-PCR) test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal swab, mid-turbinate nasal swab, and bronchoalveolar lavage (BAL) fluid from individuals suspected of COVID-19 by their healthcare provider. This test is also for use with saliva specimens that are self-collected at home or in a healthcare setting by individuals using the Spectrum Solutions LLC SDNA-1000 Saliva Collection Device when determined to be appropriate by a healthcare provider. Testing is limited to Rutgers Clinical Genomics Laboratory (RCGL) at RUCDR Infinite Biologics – Rutgers University, Piscataway, NJ, that is a Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a certified high-complexity laboratory. Results are for the detection and identification of SARS-CoV-2 RNA. The SARS- CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection.
    [Show full text]
  • Case Study: Leroy Hood / February 10, 2021
    Case Study: Leroy Hood / February 10, 2021 CASE STUDY: LEROY HOOD Introduction Leroy Hood is an inventor, entrepreneur, and in the vanguard of molecular biotechnology and genomics. He co-founded systems biology: an interdisciplinary, holistic approach to biomedical research that focuses on how molecules operate together. His inventions include the gas liquid phase protein sequencer, protein synthesizer, DNA sequencer, DNA synthesizer, the ink-jet-based DNA synthesizer (large-scale DNA synthesis) and the nanostring technology for single-molecule DNA and RNA analyses. Taken together, these six instruments have formed the technological foundation for much of the research conducted in the biotechnology- and genomics-related fields today. Hood received the Lemelson- MIT Prize in 2003 for his revolutionary innovations, which led to new, comprehensive knowledge of the factors that contribute to human disease and Leroy Hood (Photo/Dale DeGabriele) wellness. Background and Early Life Born between mountain ranges in Missoula, Montana, Leroy Hood cultivated an early fascination with the natural world and a lifelong affinity for physical fitness. He spent much of his childhood at his grandfather’s ranch in the Beartooth Mountains, and his family encouraged exploration, independence and excellence in all endeavors. Hood’s interest in biology began with the birth of his younger brother who was diagnosed with Down syndrome. At the time, the scientific community had no way of explaining why some babies were born with this condition, and Hood’s curiosity about biological conundrums and the human complexities they dictated began to grow. Hood’s family moved to Shelby, Montana, at the start of his high school career.
    [Show full text]
  • DNA Fragment Analysis by Capillary Electrophoresis User Guide
    USER GUIDE DNA Fragment Analysis by Capillary Electrophoresis Publication Number 4474504 Revision B For Research Use Only. Not intended for use in diagnostic procedures. For Research Use Only. Not intended for use in diagnostic procedures. The information in this guide is subject to change without notice. DISCLAIMER LIFE TECHNOLOGIES CORPORATION AND/OR ITS AFFILIATE(S) DISCLAIM ALL WARRANTIES WITH RESPECT TO THIS DOCUMENT, EXPRESSED OR IMPLIED, INCLUDING BUT NOT LIMITED TO THOSE OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. TO THE EXTENT ALLOWED BY LAW, IN NO EVENT SHALL LIFE TECHNOLOGIES AND/OR ITS AFFILIATE(S) BE LIABLE, WHETHER IN CONTRACT, TORT, WARRANTY, OR UNDER ANY STATUTE OR ON ANY OTHER BASIS FOR SPECIAL, INCIDENTAL, INDIRECT, PUNITIVE, MULTIPLE OR CONSEQUENTIAL DAMAGES IN CONNECTION WITH OR ARISING FROM THIS DOCUMENT, INCLUDING BUT NOT LIMITED TO THE USE THEREOF. TRADEMARKS All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. AmpErase, AmpliTaq, AmpliTaq Gold, and TaqMan are registered trademarks of Roche Molecular Systems, Inc. AFLP is a registered trademark of Keygene N.V. Millipore is a registered trademark of Merck KGaA. © 2014 Thermo Fisher Scientific Inc. All rights reserved. Contents About This Guide . 13 Revision history . 13 Purpose . 13 Prerequisites . 13 Structure of this guide . 14 ■ CHAPTER 1 Introduction to Fragment Analysis . 15 Fragment analysis versus sequencing…what is the difference? . 15 Fragment analysis . 15 Sequencing . 16 What can I do with fragment analysis? . 16 Types of applications . 16 Applications described in this guide . 17 What is capillary electrophoresis? . 18 Fragment analysis workflow . 19 ■ CHAPTER 2 Experimental Design .
    [Show full text]
  • Supporting Information Supplementary Methods
    Supporting Information Supplementary methods This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Caly L, Druce J, Roberts J, et al. Isolation and rapid sharing of the 2019 novel coronavirus (SAR-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med J Aust 2020; doi: 10.5694/mja2.50569. Supplementary methods 1.1 Generation of SARS-CoV-2 cDNA 200μL aliquots from swab (nasopharyngeal in VTM), sputum, urine, faeces and serum samples were subjected to RNA extraction using the QIAamp 96 Virus QIAcube HT Kit (Qiagen, Hilden, Germany) and eluted in 60μL. Reverse transcription was performed using the BioLine SensiFAST cDNA kit (Bioline, London, United Kingdom), total reaction mixture (20μL), containing 10μL RNA extract, 4μL 5x TransAmp buffer, 1μL reverse transcriptase and 5μL nuclease-free water. The reactions were incubated at 25°C for 10 min, 42°C for 15 min and 85°C for 5 min. 1.2 Nested SARS-CoV-2 RT-PCR and Sanger sequencing A PCR mixture containing 2μL cDNA, 1.6 μl 25mM MgCl2, 4μL 10x Qiagen Taq Buffer, 0.4μL 20mM dNTPs, 0.3μL Taq polymerase (Qiagen, Hilden, Germany) and 2μL of 10 μM primer pools as described2. Briefly, first round included the forward (5'-GGKTGGGAYTAYCCKAARTG-3') and reverse (5'-GGKTGGGAYTAYCCKAARTG-3') primers. Cycling conditions were 94°C for 10min, followed by 30 cycles of 94°C for 30s, 48°C for 30s and 72°C for 40s, with a final extension of 72°C for 10 min.
    [Show full text]
  • Isolating Microsatelline DNA Loci*
    Isolating Microsatelline DNA Loci* Travis C. Glenn1,2 and Nancy A. Schable1,2 1Savannah River Ecology Laboratory, University of Georgia, Drawer E, Aiken, SC 29802, USA 2Department of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA Contact: Travis Glenn: Phone 803-725-5746; Fax 803-725-3309; E-mail: [email protected] Abstract A series of techniques are presented to construct genomic DNA libraries highly enriched for microsatellite DNA loci. The individual techniques used here derive from several published protocols, but have been optimized and tested in our research labs as well as classroom settings at the University of South Carolina and University of Georgia, with students achieving nearly 100% success. Reducing the number of manipulations involved has been a key to success, decreasing both the failure rate and the time necessary to isolate loci of interest. These protocols have been successfully used in our lab to isolate microsatellite DNA loci from more than 125 species representing all eukaryotic kingdoms. Using these protocols, the total time to identify candidate loci for primer development from most eukaryotic species can be accomplished in as little as one week. *This information is based on (i.e., PLEASE CITE [using either style]): Glenn, T.C. and N.A. Schable. 2005. Isolating microsatellite DNA loci. Methods in Enzymology 395:202-222. or Glenn TC, Schable NA (2005) Isolating microsatellite DNA loci. Pp. 202-222 In: Methods in Enzymology 395, Molecular Evolution: Producing the Biochemical Data, Part B. (eds Zimmer EA, Roalson EH). Academic Press, San Diego, CA. Isolating Microsatellite DNA Loci p.2 Microsatellite DNA loci have become important sources of genetic information for a variety of purposes (Goldstein and Schlotterer, 1999; Webster and Reichart 2004).
    [Show full text]
  • Portable DNA Sequencer Helps Farmers Stymie Devastating Viruses INNER WORKINGS Leah Shaffer, Science Writer
    INNER WORKINGS Portable DNA sequencer helps farmers stymie devastating viruses INNER WORKINGS Leah Shaffer, Science Writer Armed with a battery-operated minicomputer, a hand- The researchers call themselves an “action group” held DNA sequencer, and portable DNA-extraction ma- because they’re “taking the level of knowledge we get chine, researchers gathered in a cassava field in Tanzania as scientists, down to the farmer,” says Peter Sseruwagi, last August to chase down a major plant pest. Their plan a research scientist at Mikocheni Agricultural Research was unprecedented: sequence the whole genome of Institute (MARI) in Tanzania. “We’re able to show the the plant material to detect all potential viruses—and farmer in a single day, what their crops are infected dosoinasingledayonafarm.“We called it tree lab, we with.” were sitting under a tree,” says Laura Boykin, a compu- This is a big deal, especially in Africa, where cassava, tational biologist at the University of Western Australia. a sweet potato–like starch, is intricately tied to lives and Because plant samples are typically sent overseas livelihoods for many of the people on the continent. to test for viruses, there’s a big distance between the The two main cassava diseases, cassava brown streak farm and the laboratory—thousands of miles if you’re virus and cassava mosaic disease (CMD), are estimated in eastern Africa. But within a few hours, a group of to cause a loss of $2 billion to $3 billion annually (1). researchers, part of the Cassava Virus Action Project, CMD alone can cause loss of up to 40% of a crop (2).
    [Show full text]